Nafcillin
- Product NDC
- 70860-117
- 11-digit product format
- 708600117
- Labeler code
- 70860
- Product ID
- 70860-117_62ea9c63-6f78-4848-b3ab-4ae9bcc5b39a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- nafcillin sodium
- Dosage form
- POWDER, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA090560
- Marketing category
- ANDA
- Marketing start
- 2018-08-01
- Marketing end
- 0000-00-00
- Substance
- NAFCILLIN SODIUM
- Active strength
- 2 g/1
- Pharmacologic classes
- Penicillin-class Antibacterial [EPC], Penicillins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70860-117 | NAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [ATHENEX PHARMACEUTICAL DIVISION, LLC.] | 5 | Legacy NDC | 20240306_803fddee-c2d5-47e8-af7f-0caa38093ca6.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-117-26 | 70860011726 | 10 VIAL in 1 CARTON (70860-117-26) > 1 POWDER, FOR SOLUTION in 1 VIAL (70860-117-41) | 10 vial | 2018-08-01 | 0000-00-00 | No | No | Current |